IDHIFA (enasidenib)

SELF ADMINISTRATION

Indications for Prior Authorization:

  • Treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with isocitrate dehydrogenase-2 (IDH2) positive mutation as detected by an FDA-approved test

All of the following must be met as a condition for coverage:

  • Prescribed by an oncologist, AND
  • Patient is 18 years or older, AND
  • Confirmed presence of IDH2 mutations in the blood or bone marrow

Dosing:

  • 100 mg orally once daily

Approval:

  • 1 year

Last review date: September 4, 2018

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone